Active Care Model Predicts Disease Course for Prostate Cancers

Active Care Model Predicts Disease Course for Prostate Cancers

For many men, prostate cancers are extremely slow-growing — patients often can be monitored periodically through blood tests, biopsies and MRI without necessarily needing treatment. Johns Hopkins experts have a precision medicine tool — called Active Care — that employs sophisticated statistical modeling and all of the patient’s prostate-specific antigen (PSA) protein level tests, biopsy results and other clinical information to estimate the chance that the cancer is slow-growing or more aggressive.

 READ HERE
SEE ALL NEWS
Recent Posts
Study Suggests a Healthy Diet May Help Keep Low Grade Prostate Cancer From Progressing to More Dangerous States During Active Surveillance Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models Johns Hopkins Joins Cancer AI Alliance AI ‘Liquid Biopsies’ Using Cell-Free DNA, Protein Biomarkers, Could Aid Early Detection of Ovarian Cancer A Common Culprit Drives Prostate Cancer Progression Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence Age-Related Changes in Male Fibroblasts Increase Treatment-Resistant Melanoma Scientists Identify Potential New Immune System Target to Head Off the Spread of Breast Cancer Cells Johns Hopkins Researchers Identify Key Markers in Pancreatic Cancer Progression Using a New Analysis Pipeline